Cardiovascular disease (1.6, 1.5, 1.7)
On this page
Atherosclerosis is the buildup of fatty deposits (atheromas) that go on to form plaques within the arterial walls.
Plaque formation leads to narrowing and hardening of the arteries. This leads to elevated blood pressure, as well as blockages and/or ruptures in the arterial network.
When a blockage occurs in the coronary artery, it can lead to a heart attack.
When the blockage or rupture impacts the blood supply to the brain, it can result in a stroke.

Atherosclerosis begins with endothelial dysfunction.
The endothelium is the thin, smooth inner lining of blood vessels.
Damage to the endothelium of the artery can be caused by:
- high blood pressure (mechanical stress)
- toxins from cigarette smoke
- high blood cholesterol.
Veins are less vulnerable to endothelial dysfunction because of their lower blood pressure. Once damaged or overstretched, the endothelium becomes leaky, triggering an inflammatory response.
When damage to the endothelium is detected by the immune system, an inflammatory response is triggered.
White blood cells (macrophages) move into the artery wall and accumulate fatty chemicals from the blood, such as cholesterol. The buildup of fatty deposits forms a fatty streak called an atheroma.
Calcium salts and fibrous tissue build up over the atheroma, forming a hard lump on the inner wall of the artery called a plaque.
Arterial plaques cause:
- Narrowing (stenosis) of the artery lumen leading to reduced blood flow and increased blood pressure.
- Loss of elasticity of the artery wall (arteriosclerosis).
Blood clotting (also called coagulation) is a vital process that prevents excessive bleeding when a blood vessel is damaged. It also prevents the entry of pathogens and provides a scab, under which healing occurs.
Inappropriate or excessive clot formation inside arteries can contribute to cardiovascular disease (CVD), such as coronary heart disease and stroke.

During clotting:
- Thromboplastin (a protein) is released from damaged tissues and platelets.
- Thromboplastin, alongside ions, trigger the release of an enzyme converting the protein prothrombin to the enzyme thrombin.
- Thrombin catalyses the conversion of soluble fibrinogen (a plasma protein) into insoluble fibrin.
- Fibrin fibres form a mesh network across the wound.
- The fibrin mesh traps red blood cells and platelets, forming a stable blood clot (thrombus). The clot seals damaged vessels, preventing blood loss and entry of pathogens.
Atherosclerosis increases the risk of excessive or inappropriate blood clotting.
Plaques (atheromas) can rupture, exposing the underlying collagen and tissue. This triggers the clotting cascade at the plaque site, even though there’s no external injury. A blood clot (thrombus) forms within the already narrowed artery.
Consequences of inappropriate clotting include:
- Narrowing or blockage of the artery causes restricted blood flow.
- If the clot blocks a coronary artery it causes heart attack (myocardial infarction). The heart does not receive enough oxygen, so heart cells cannot respire and produce ATP. The force of a heart contraction is reduced, and heart cells die.
- If the clot blocks a cerebral artery it causes stroke as blood flow to the brain is restricted, so brain cells cannot respire and produce ATP and therefore die. This type of stroke is known as an ischemic stroke.
Risk factors are established by investigating the proportion of people within a given subset who go on to exhibit a specific response variable within a specific time.
The proportion is usually conveyed as “x in y” rather than as a percentage to give more meaning to the figure. The specific time can vary; it could be per dose, per year or per lifetime.
There are many different risk factors associated with the likelihood of developing cardiovascular disease.



